Copy
A-Labs Capital II Corp. Seeks Resumption of Trading on TSX Venture Exchange
TORONTO, ONTARIO — July 28, 2025 — Leads & Copy — A-Labs Capital II Corp. (TSXV: ALAB-P.V) has applied to the TSX Venture Exchange for the resumption of trading of its common shares, which were halted on October 2, 2020, following a non-binding letter of intent with RDARS Inc. The transaction with RDARS Inc. was terminated on March 22, 2021, and the shares have remained halted. No monies were advanced, and no residual liabilities exist from the terminated transaction.
The company acknowledges it is deficient in meeting Exchange requirements for annual general meetings (AGM), not having held one since March 11, 2021. Delays were initially due to successive letters of intent for qualifying transactions. After the last termination on March 22, 2023, the company's financial position inhibited its ability to hold an AGM.
An investor group has indicated a willingness to provide financing, contingent upon the resumption of trading. The company intends to call an AGM as soon as possible, no later than September 16, 2025, dependent on financing completion, which in turn depends on the resumption of trading.
If the application is accepted, the company will be placed on a 90-day Exchange Notice due to its failure to hold an AGM within the required 15-month period, per Exchange Policy 3.2, Section 4.1.
Contact: Doron Cohen, Chief Executive Officer, Telephone: (972)54-522-4017, E-mail: Doron@alabs.co
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2025 TheNewswire - All rights reserved.